Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 09/906,251, filed Jul. 16, 2001. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/081,501, filed Feb. 21, 2002. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/081,943, filed Feb. 21, 2002. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/081,764, filed Feb. 21, 2002. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/081,606, filed Feb. 21, 2002. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/081,761, filed Feb. 21, 2002. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/081,713, filed Feb. 21, 2002. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/193,600, filed Jul. 11, 2002. |
Ortho-McNeil Pharmaceutical, Inc., U.S. patent application Ser. No. 10/192,973, filed Jul. 11, 2002. |
Saddock, B.J. et al., Treatment of Bipolar Disorders, Comprehensive Textbook of Psychiatry, 2000, vol. 1, 1385-1430. |
Post, R.M., et al., A History of the use of anticonvulsants as Mood Stabilizers in the Last Two Decades of the 20th Century, Neuropsychobiology, 1998, 38 (3), Abstract. |
Diagnostic and Statistical Manual of Mental Disorders, Edition 4, American Psychiatric Association, Washington D.C., 1994. |
Akiskal, H.S., et al. Re-evaluating the Prevalence of and Diagnostic Composition Within the Broad Clinical Spectrum of Bipolar Disorders, J. Affect. Disord., 2000, 59 (Suppl 1), S5-S30. |
Goodwin, F. K., et al., Manic-Depressive Illness, Oxford University Press, New York, 1990, pp. 405-407. |
Ghaemi, S. N., et al., Kindling and Second Messengers: An Approach to the Neurobiology of Recurrence in Bipolar Disorder, Bio. Psychiatry, 1999, 45(2), 137-144. |
Stoll, A.L., et al., Mood Stabilizers: Shared Mechanisms of Action at Postsynaptic Signal-Transduction and Kindling Processes, Harv. Rev. Psychiatry, 1996, 4(2), 77-89. |
Goldberg, J.F., et al., Kindling in Bipolar Disorders: A Longitudinal Follow-Up Study, Biol. Psychiatry, 1994, 1; 35(1), 70-72. |
Janowsky, D.S., New Treatments of Bipolar Disorder, Curr. Psychiatry Rep., 1999, 1(2), 111-113. |
Shelton, M.D., et al., Current Concepts in Raid Cycling Bipolar Disorder, Curr. Psychiatry Rep., 2000, 2(4), 310-315. |
Lennkh, C., et al., Current Aspects of Valproate in Bipolar Disorder, Int. Clin. Psychopharmacol., 2000, 15(1), 1-11. |
Tohen, M., et al., Management of Acute Mania, J. clin. Psychiatry, 1999, 60 (Suppl 5) 31-34. |
Muller-Oelinghausen, B., et al., Valproate as an Adjunct to Neuroleptic Medication for the Treatment of Acute Episodes of Mania: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study, European Valproate Mania Study Group, J. Clin. Psychopharmacaol., 2000, 20(2), 195-203. |
Sachs, G.S., et al., The Expert Consensus Guidelines Series: Medication Treatment of Bipolar Disorder 2000, Postgrad. Med. 2000, Spec No:1-104. |
Bipolar Disorder, Cognos Study #53, Decision Resources, Mar. 2000. |
Wauquier, A., et al., Topiramate: A Potent Anticonvulsant in the Amygdala-kindled Rat, epilepsy Res., 1996, 24, 73-77. |
International PCT Search Report, PCT/US 02/05 297 dated Jul. 15, 2002. |